Home › Funds › Millennium Management › ENTX
Millennium Management position in ENTX
ENTERA BIO LTD · Health Care
Latest position (Q1 2024)19.51K sh
Reported value held$32.58K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 18.84K | $89.00K | New |
| Q1 2022 | 46.21K | $132.00K | New |
| Q2 2022 | 16.86K | $22.00K | Reduce |
| Q3 2022 | 10.03K | $10.00K | Reduce |
| Q4 2022 | 46.00K | $34 | Add |
| Q3 2023 | 11.37K | $8.25K | New |
| Q4 2023 | 10.10K | $6.06K | Reduce |
| Q1 2024 | 19.51K | $32.58K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENTX
- Renaissance Technologies 368.85K sh · $652.86K · Q2 2026
- PNC Financial Services 273.03K sh · $483.26K · Q2 2026
- Citadel Advisors 48.90K sh · $86.56K · Q2 2026
- JPMorgan Chase & Co 40.88K sh · $67.46K · Q2 2026
- Geode Capital Management 29.91K sh · $52.94K · Q2 2026
- UBS Group AG 12.72K sh · $22.52K · Q2 2026
- Morgan Stanley 500 sh · $885 · Q2 2026